Isomorphic Labs focuses on harnessing the power of artificial intelligence to improve drug discovery. By using AI-driven models, it assists researchers in predicting molecular interactions and optimizing compounds, facilitating the design of new medications with enhanced precision and speed. The platform aims to reduce the time and cost associated with traditional drug development methods.

Lavo AI is designed to revolutionize drug development with AI-powered crystal structure prediction for small molecule drugs. By utilizing sophisticated physically-constrained AI algorithms trained on extensive datasets, it can analyze millions of potential crystal structures in just days. This advanced tool identifies novel polymorphs and explores environmental factors affecting these structures, greatly reducing the time and cost traditionally associated with drug development.